These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8936438)

  • 61. Emergency contraception: politics trumps science at the U.S. Food and Drug Administration.
    Grimes DA
    Obstet Gynecol; 2004 Aug; 104(2):220-1. PubMed ID: 15291989
    [No Abstract]   [Full Text] [Related]  

  • 62. OTC drugs: categories I, II, and III.
    Whitehill D
    S D J Med; 2003 Jun; 56(6):221-2. PubMed ID: 12827937
    [No Abstract]   [Full Text] [Related]  

  • 63. The FDA's drug review process: ensuring drugs are safe and effective.
    Meadows M
    FDA Consum; 2002; 36(4):19-24. PubMed ID: 12184298
    [No Abstract]   [Full Text] [Related]  

  • 64. FDA yanks leg cramp products off the OTC market.
    Chase SL
    RN; 1995 May; 58(5):71. PubMed ID: 7747043
    [No Abstract]   [Full Text] [Related]  

  • 65. New approval requirement for pancreatic drugs.
    FDA Consum; 2004; 38(4):5. PubMed ID: 15346565
    [No Abstract]   [Full Text] [Related]  

  • 66. The FDA, politics, and plan B.
    Stanford JB; Hager WD; Crockett SA
    N Engl J Med; 2004 Jun; 350(23):2413-4; author reply 2413-4. PubMed ID: 15179695
    [No Abstract]   [Full Text] [Related]  

  • 67. New drug approvals in 1996.
    Wynn RL
    Gen Dent; 1997; 45(3):224-7. PubMed ID: 9515422
    [No Abstract]   [Full Text] [Related]  

  • 68. HIV drugs. FDA new drug approval rate lowest in 10 years.
    AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17323437
    [No Abstract]   [Full Text] [Related]  

  • 69. Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA Modernization Act of 1997.
    Kulynych J
    Food Drug Law J; 1999; 54(1):127-49. PubMed ID: 11758555
    [No Abstract]   [Full Text] [Related]  

  • 70. Accelerated approval of oncology products: the food and drug administration experience.
    Johnson JR; Ning YM; Farrell A; Justice R; Keegan P; Pazdur R
    J Natl Cancer Inst; 2011 Apr; 103(8):636-44. PubMed ID: 21422403
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Allergy warning.
    Underwood A
    Newsweek; 2002 Dec; 140(24):88. PubMed ID: 12500716
    [No Abstract]   [Full Text] [Related]  

  • 72. Has the food and drug administration changed the drug approval process?
    Somberg JC
    Am J Ther; 2011 May; 18(3):179. PubMed ID: 21566467
    [No Abstract]   [Full Text] [Related]  

  • 73. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plan B available to women 18 and older in US.
    Korcok M
    CMAJ; 2006 Oct; 175(8):862. PubMed ID: 17030935
    [No Abstract]   [Full Text] [Related]  

  • 75. Nonprescription version of famotidine wins FDA approval.
    Am J Health Syst Pharm; 1995 Jul; 52(13):1377. PubMed ID: 7671034
    [No Abstract]   [Full Text] [Related]  

  • 76. Advertising medicines to the public.
    George CF
    J R Coll Physicians Lond; 1996; 30(2):102-3. PubMed ID: 8709051
    [No Abstract]   [Full Text] [Related]  

  • 77. FDA advisers vote against nonprescription lovastatin.
    Traynor K
    Am J Health Syst Pharm; 2005 Mar; 62(5):455-6, 460. PubMed ID: 15745902
    [No Abstract]   [Full Text] [Related]  

  • 78. 2014 update: drugs on the horizon.
    Johnson MS
    Nurs Manage; 2014 Feb; 45(2):26-32; quiz 32-3. PubMed ID: 24407280
    [No Abstract]   [Full Text] [Related]  

  • 79. Drugs and medical ethics.
    Somogyi E
    Med Law; 1993; 12(1-2):29-31. PubMed ID: 8377616
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chinese herbal medicines.
    Nutr Rev; 1974 Oct; 32(10):317. PubMed ID: 4412418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.